Society Pass (SOPA) Plans to Spinout of Two Units Into New Publicly-Traded Companies via...
NEW YORK, NY, Oct. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Society Pass Inc. ( Nasdaq: SOPA ) (“ SoPa ” or the “ Company ”), Southeast Asia’s (“ SEA ”) next generation,...
Dawson James Securities 8th Annual Small Cap Growth Conference.
Presenting Company List
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Dawson James Securities, Inc. (“Dawson”), a full-service...
Ouch…Omniq (OMQS).
We had fun with this for a good year, doubling after we found it.
Adding OmniQ (OMQS) $5.00...
Greatest Interview with Arthur Hayes.
38-year-old Arthur Hayes who hails from Detroit, with a estimated net worth of $500 million, and has posted a fantastic interview. It's...
Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction
“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.”
Is Ardelyx (ARDX) $4.00 Ready to Break Out?
We're up 160% ($579 million) in Ardelyx since adding it to the Watch List about ten months ago in November, but we...
The Resurgence Of Selling Shareholders In Microcap IPOs
Forbes Finance Council
In today’s capital markets landscape, the initial public offering market is experiencing significant challenges, especially for...
Clever and Sophisticated Bing Chat AI Malware Ads.
Imagine asking Bing Chat a question..
"Hello Bing, I would like to download advanced IP scanner"
Bionix (BNOX) up 316% on PTSD News.
Can't say we'd buy this now, but fun to watch. With a $35 million market cap, it now belongs to the night...
Digital Coaches at Dario (DRIO) Significantly Reduce Depression.
63% of Users Show Significant Improvement After Impact of Digital Coaching and Breathing Exercises as Part of the Dario Health Platform.
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
